Clinical Trial Results:
            A Randomized, Double-Blind, Placebo and Active-Controlled, 4-Arm, Parallel-Group,  Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-28431754 (Canagliflozin) Compared with Sitagliptin and Placebo in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy.
    
| 
                 Summary 
         | 
        |
    EudraCT number  | 
        2009-016525-34 | 
    Trial protocol  | 
        LV BG PT PL SK CZ EE SE GR IT | 
    Global completion date  | 
        
                                    29 May 2012
                             
         | 
    
| 
                 Paediatric regulatory details 
         | 
        |
    Is the trial part of an agreed EMA paediatric investigation plan?  | 
        
                                        No
                                 
         | 
    
    Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?  | 
        
                                        No
                                 
         | 
    
    Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?  | 
        
                                        No
                                 
         | 
    
| 
                 Results information 
         | 
        |
    Results version number  | 
        v1(current) | 
    This version publication date  | 
        
                                    19 Aug 2016
                             
         | 
    
    First version publication date  | 
        
                                    19 Aug 2016
                             
         | 
    
    Other versions  | 
        |
    Summary report(s)  | 
                                28431754DIA3006 (2009-016525-34)_Ct.gov Results | 
    
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.